• Use Of Factor Analysis To Obtain Independent Health Performance Indicators

    Nov 1, 2014, 00:00
  • Do Quality or Efficiency Indicators Inside French P4p Perimeter Influence Quality Or Efficiency Indicators Outside P4p?

    Nov 1, 2014, 00:00
  • Health Care Resource Requirements and Costs During the Recovery Phase of Fasciectomy for the Treatment of Dupuytren's Contracture- Clinician Survey

    Nov 1, 2014, 00:00
  • Health Insurance Cost of Anxiety in Hungary- A Cost of Illness Study

    Nov 1, 2014, 00:00
  • The Expanding Role Of The Patient Voice In Medical Decision Making In Asia

    Nov 1, 2014, 00:00
  • Cost Per Responder Of Apremilast Versus Etanercept And Adalimumab In Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00
  • Projecting Health Gains- The Population Impact of New Treatments to Metastatic Breast Cancer

    Nov 1, 2014, 00:00
  • Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012

    Nov 1, 2014, 00:00
  • Treatment Patterns And Quality Of Life Of Patients With Non-Valvular Atrial Fibrillation- An Experience Of A Tertiary Health Care Centers (Treq-Af Study)

    Nov 1, 2014, 00:00
  • Trend Comparison of the Colombian Multidimensional Poverty Index, Inequities in Maternal Mortality, Neonatal Mortality and Gini Coefficient, 1997-2011

    Nov 1, 2014, 00:00
  • Graphical Interactive Meta-Analysis Module for Facilitating Evidence-Based Decision Making in Health Care

    Nov 1, 2014, 00:00
  • The Evolution of International Reference Pricing- An Analysis of 39 Countries

    Nov 1, 2014, 00:00
  • Resource Utilization Pattern And Cost Of Tuberculosis Treatment In Penang, Malaysia

    Nov 1, 2014, 00:00
  • HOW SINGLE ARM PHASE II DATA CAN SUPPORT REIMBURSEMENT FOR ONCOLOGICS IN AUSTRALIA

    Nov 1, 2014, 00:00
  • Estimation of Increased Costs in Switching from Tiotropium to Other Lama Therapy During Maintenance Treatment of COPD in the UK

    Nov 1, 2014, 00:00
  • Characterizing Work Productivity Loss In Incident Rheumatoid Arthritis In Sweden

    Nov 1, 2014, 00:00
  • Effect of Smoking Status on Health Care Costs In Patients With Type 2 Diabetes- A Retrospective Nested Case-Control Economic Study In Routine Clinical Practice

    Nov 1, 2014, 00:00
  • Why Does Anti-Infective Drug Expenditure Increase?-a Decomposition Analysis on China Data

    Nov 1, 2014, 00:00
  • The Epidemiologic Burden of Hepatitis C Virus Infection in Egypt

    Nov 1, 2014, 00:00
  • Key Cost Drivers Of Type 2 Diabetes Mellitus- an International Literature Review

    Nov 1, 2014, 00:00
  • Critical Appraisal Of Network Meta-Analyses Evaluating The Efficacy And Safety Of New Oral Anticoagulants In Atrial Fibrillation Stroke Prevention Trials

    Nov 1, 2014, 00:00
  • Improving Performance in Diabetes Care- Benefits of Information Technology Enabled Diabetes Management

    Nov 1, 2014, 00:00
  • A Methodology for Estimating the Population of Advanced or Metastatic EGFR M+ Non-Small Cell Lung Cancer Patients in the UK and Ireland

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Of Ldl-P-Guided Statin Therapy

    Nov 1, 2014, 00:00
  • Health-Related Quality of Life in Migraine Without Aura Based on Attack Frequency- A time Trade-Off Study

    Nov 1, 2014, 00:00
  • Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?

    Nov 1, 2014, 00:00
  • Translation and Linguistic Validation of Two COPD Symptom Diaries (Nicsi And Emsci) for Use in 14 Countries

    Nov 1, 2014, 00:00
  • Hydroxyethyl Starch And Hospitalized Mortality In Icu Patients With Diabetes- Database Study From A Chinese Tertiary Hospital

    Nov 1, 2014, 00:00
  • A Payers Perspective to Pharmaceutical Market Access- Defining Market Access

    Nov 1, 2014, 00:00
  • Cost Utility Analysis of Ustekinumab for the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Thailand

    Nov 1, 2014, 00:00
  • Attitude Change Among 18-19 Years Old Boys After School-Drug Prevention Program

    Nov 1, 2014, 00:00
  • Health State Utility Valuation in Radio-Iodine Refractory Differentiated Thyroid Cancer (RR-DTC)

    Nov 1, 2014, 00:00
  • Economic Assessment of Delaying Insulin Treatment Through The Use of Newer Anti-Diabetic Agents, Dapagliflozin (Forxiga®) And Exenatide (Bydureon®), Both As Add-On To Metformin; A Cost-Effectiveness Analysis From A Uk Nhs Perspective

    Nov 1, 2014, 00:00
  • Effectiveness Of Herbotrim And Muniprabha In The Management Of Hypothyrodism

    Nov 1, 2014, 00:00
  • How is Research and Development Innovation Evolving? Focus on Oncology and Cardiovascular Disease

    Nov 1, 2014, 00:00
  • Mental Component of the Quality of Life Increased According to the Level of Obesity

    Nov 1, 2014, 00:00
  • Disability-Adjusted Life Years (Dalys) as a Composite Measure to Express the Burden of Tick-Borne Encephalitis (Tbe) in Slovenia

    Nov 1, 2014, 00:00
  • Health Care Utilization and Cost of Management in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thailand

    Nov 1, 2014, 00:00
  • Community Pharmacist Perceptions of Generic Medicines- A Survey in Tehran

    Nov 1, 2014, 00:00
  • Health Related Quality of Life and Patient Satisfaction in Prostate Cancer Patients Treated Through Radical Prostatectomy

    Nov 1, 2014, 00:00
  • The Endometriosis Health Profile (Ehp) – A Case Study of Successful Epro Collaboration

    Nov 1, 2014, 00:00
  • Retrospective Database Study on Health Care Resource Utilization of Patients Initiating Long-Acting Olanzapine in Sweden

    Nov 1, 2014, 00:00
  • Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab

    Nov 1, 2014, 00:00
  • Impact Laws And Decrees On Activities- The Ilda Study

    Nov 1, 2014, 00:00
  • A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective

    Nov 1, 2014, 00:00
  • Health Related Quality of Life Outcomes (Hrqol) and Resource Use Associated With Type 2 Diabetes Patients Taking Steps To Lose Weight In 5 European Countries

    Nov 1, 2014, 00:00
  • The Intermediate Burden Of Diabetes Mellitus In Patients With Cardiovascular Disease (Cvd)- A Quality Adjusted Life Year (Qaly) -Analysis Based On Primary Longitudinal Data

    Nov 1, 2014, 00:00
  • COST- MINIMIZATION ANALYSIS OF THE DIRECT COSTS OF SEVELAMER CARBONATE AND LANTHANUM CARBONATE IN THE TREATMENT OF CKD-ND PATIENTS

    Nov 1, 2014, 00:00
  • Health-Related Quality Of Life Impact Of Triple Combinations Of Olmesartan Medoxomil, Amlodipine Besylate And Hydrochlorothiazide In Subjects With Hypertension

    Nov 1, 2014, 00:00
  • Treatment Reasons, Resource use and Costs of Hospitalisations in People with Parkinson's- Results from a Large Rct

    Nov 1, 2014, 00:00
  • Identifying Consistent Inconsistency in Network Meta-Analyses - An Illustration In Type 2 Diabetes

    Nov 1, 2014, 00:00
  • Cost Effectiveness Of Ivabradine In Chronic Heart Failure Patients With Heart Rate Above Bpm In Taiwan

    Nov 1, 2014, 00:00
  • Quality of Life in Patients Undergoing Hemodialysis- A Vision of the Influence of Time

    Nov 1, 2014, 00:00
  • Hospital Drg Costing and Health Services Use of Very Pre-Term Infants From the Proprems Neuro Study Across 10 Hospitals in Australia and New Zealand

    Nov 1, 2014, 00:00
  • Effect of Vitamin E on the Vaginal Atrophy of Postmenopausal Women

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]- >3.5–5.0)

    Nov 1, 2014, 00:00
  • Diagnosing Anxiety Disorders in Primary Care- a Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00
  • A Cost-Effectiveness Analysis Of Interventions For Symptomatic Varicose Veins

    Nov 1, 2014, 00:00
  • Assessing the Relationship Between Patient Compliance to Blood Glucose Monitoring and Health Related Quality of Life

    Nov 1, 2014, 00:00
  • Determination of Major Chronic Diseases by Using Pharmaceutical Reimbursement Data From A Large Belgian Health Insurer Claims Database

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis Of Antiviral Pharmacotherapies For Treatment Of Chronic Hepatitis C Virus Infection In Russia

    Nov 1, 2014, 00:00
  • Interchangeability Study of Multisource Paracetamol 500mg Tablets, Produced in Mongolia

    Nov 1, 2014, 00:00
  • Encumberance to the Treatment of Osteoporosis- Physicians and Patient Perception

    Nov 1, 2014, 00:00
  • An Assessment Of The Current Literature On Apheresis Use In The Treatment Of Familial Hypercholesterolemia

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of the Original Drug Arglabin

    Nov 1, 2014, 00:00
  • An Evaluation of the Comparative Effectiveness of Clomethiazole Against Diazepam in the Treatment of Alcohol Withdrawal Syndrome in Routine Clinical Practice

    Nov 1, 2014, 00:00
  • External Reference Pricing Impact of the Integration of the Amnog Discount In The List Price

    Nov 1, 2014, 00:00
  • Patterns and Trends In Opioid Use In Iran From 2007 To 2011

    Nov 1, 2014, 00:00
  • A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database

    Nov 1, 2014, 00:00
  • Review on Medicines Prices and Availability in Indonesia- 2004 To 2012

    Nov 1, 2014, 00:00
  • Towards a Framework for Analysing Sustainability of Economic Value- The Case of a Short Stay Programme for Breast Cancer Surgery Care Five Years After Implementation

    Nov 1, 2014, 00:00
  • What are the Health Care Resource Utilization and Medical Cost of Untreated Patients with Neuroendocrine Tumors in the United States?

    Nov 1, 2014, 00:00
  • A Cost-Utility Analysis of Sacral Anterior Root Stimulation (SARS) Compared to Medical Treatment in Complete Spinal Cord Injured Patients with a Neurological Bladder

    Nov 1, 2014, 00:00
  • Economic And Quality-Of-Life Burden Of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Spain- The Ibis-C Study

    Nov 1, 2014, 00:00
  • Market Access for Medical Devices- Adapting to Change

    Nov 1, 2014, 00:00
  • Health Technology Assessments In Oncology- Crizotinib Case Study

    Nov 1, 2014, 00:00
  • Impact Evaluation of Provider Payment Reform Under the New Rural Cooperative Medical Scheme in Gansu Province, China

    Nov 1, 2014, 00:00
  • Comparison Of Disease Status And Outcomes Of Patients With Psoriatic Arthritis (Psa) Receiving Adalimumab Or Etanercept Monotherapy In Europe

    Nov 1, 2014, 00:00
  • Hye and me as Identical Currencies in Preference Studies? A Discrete-Choice Experiment in Type2 Diabetes Mellitus

    Nov 1, 2014, 00:00
  • Usability Testing of A Novel Pain Medication Diary Administered Electronically

    Nov 1, 2014, 00:00
  • Doctors' Failure in Observance of the COPD Management Guidelines- Case of the CZECH Republic

    Nov 1, 2014, 00:00
  • An Analysis of Pricing Premiums Granted Through Submitting Local RCT and Pharmacoeconomics Data in Taiwan

    Nov 1, 2014, 00:00
  • Assessment of Effect of Continuous Subcutaneous Insulin Infusion Treatment, Insulin Analog And Human Insulin of Children With Diabetes

    Nov 1, 2014, 00:00
  • Review of Pricing And Reimbursement Systems in South-Eastern Europe

    Nov 1, 2014, 00:00
  • Health-Related Quality of Life for Patients with Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2014, 00:00
  • Multicriteria Decision Analysis and Cost Analysis in Health Care Decision Making- A Literature Review

    Nov 1, 2014, 00:00
  • Dental Care Use And Associated Factors Among People With Rheumatoid Arthritis- A Nationwide, Population-Based, Propensity Score-Matched Follow-Up Study

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Sitagliptin Versus Sulfonylurea As An Add-On Therapy To Metformin In Patients With Type 2 Diabetes In A Belgium Setting

    Nov 1, 2014, 00:00
  • Economic Burden of Childhood Injury- A Review

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis Of A Personalized Therapy For Genotype 1, Naive, Chronic Hepatitis C Patients In Italy

    Nov 1, 2014, 00:00
  • Cost Effectiveness Analysis of Everolimus + Exemestane for Patients with Advanced Breast Cancer with Positive Estrogen Receptor (ER +), HER2-, Refractory to Non-Steroidal Aromatase Inhibitors (NSAIS) in Chile

    Nov 1, 2014, 00:00
  • Human Epididymis Protein 4 Test

    Nov 1, 2014, 00:00
  • COST EFFECTIVENESS ANALYSIS OF ANTIDEPRESSANTS ON BREAST CANCER PATIENTS- A MARKOV MODELING STUDY

    Nov 1, 2014, 00:00
  • Health Technology Assessment, Price and Reimbursement Review for Orphan Drugs In France

    Nov 1, 2014, 00:00
  • Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain

    Nov 1, 2014, 00:00
  • Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 96-Week Results of the Rapid ...

    Nov 1, 2014, 00:00
  • What Is The Patients' Median Delay From The Referring Community Health Worker To Arrival in the Link Health Facility?

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of denosumab vs. Brand or generic zoledronic acid in patients with prostate cancer in kazakhstan

    Nov 1, 2014, 00:00
  • IMTA Productivity Cost Questionnaire (IPCQ)

    Nov 1, 2014, 00:00
  • The Cost of Active Systemic Lupus Erythematosus in Greece Results From the Lycos Study

    Nov 1, 2014, 00:00
  • Process Mapping to Capture Breast Cancer Patients' Journey in Greek Public Oncological Hospitals

    Nov 1, 2014, 00:00
  • The Measurement Of Utilities In Asthma Patients- A Preliminary Study

    Nov 1, 2014, 00:00
  • Pill Burden, Health Care Resource Utilization and Costs Among Subpopulations of Immediate Release Hydrocodone Users

    Nov 1, 2014, 00:00
  • Does diabetes have an impact on health-state utility? A study of asians in singapore

    Nov 1, 2014, 00:00
  • Understanding the Rationale for Responses to a Time-Trade-Off Assessment and Willingness-To-Pay in Lung Cancer in Thailand

    Nov 1, 2014, 00:00
  • Burden of Disease of the Mastacarcinoma in Austria

    Nov 1, 2014, 00:00
  • Cost Effectiveness of Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis

    Nov 1, 2014, 00:00
  • Evidence-Based Market Access Value Resour Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European Countries

    Nov 1, 2014, 00:00
  • A Review Of Patient Reported Outcomes (Pros) In Psoriasis According To The Food And Drug Administration (Fda) Pro Guidance Criteria

    Nov 1, 2014, 00:00
  • Disease Management, Resource Utilisation and Associated Cost for Moderate and Severe Dementia Patients in China- Results from a Delphi Panel

    Nov 1, 2014, 00:00
  • Evidence for Validity of a National Physician and Patient-Reported Survey in China and United Kingdom- The Disease Specific Programme

    Nov 1, 2014, 00:00
  • The Association Between The Nature And Timing Of Dental Visits And C-Reactive Protein Levels

    Nov 1, 2014, 00:00
  • Modelling Survival in the Presence of Different Mechanisms of Action- Ipilimumab and Vemurafenib in Advanced Melanoma

    Nov 1, 2014, 00:00
  • Exploring the Willingness-to-Pay for Biologic Treatments In Immunology Diseases in China

    Nov 1, 2014, 00:00
  • Using Health Assessment Questionnaire – Disability Index To Estimate Eq-5d Utility Values for Patients With Rheumatoid Arthritis in Taiwan

    Nov 1, 2014, 00:00
  • Acute Respiratory Distress Syndrome- Treatment Pattern and Outcome Analysis

    Nov 1, 2014, 00:00
  • Quality Of Life – A Rarely Acknowledged Key Category Within The Amnog Process in Germany

    Nov 1, 2014, 00:00
  • Categorical Health States In Chronic Spontaneous Urticaria (Csu) Based On The Weekly Urticaria Activity Score (Uas7)- Are They Distinct, Discriminative, And Reproducible?

    Nov 1, 2014, 00:00
  • Incidence Description and Costs of Acute Heart Failure in the Netherlands

    Nov 1, 2014, 00:00
  • Modelling the Relationship between Sustained Virologic Response and Treatment Uptake Rates on Future Prevalence and Incidence of Hepatitis C in the UK

    Nov 1, 2014, 00:00
  • Studies On Clinical Effectiveness Of Combined Classical Ayurvedic Formulations In Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00
  • Guideline Adherence and Control Of Diabetes Mellitus With Co-Morbidities in a Tertiary-Care Hospital in Malaysia

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Evaluation of Brentuximab Vedotin for Refractory/Relapsed Hodgkin Lymphoma- A Comparative Analysis of the Results of Mexico and Venezuela

    Nov 1, 2014, 00:00
  • Cost-Utility Analysis of Pazopanib Verse Sunitinib as First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC) iN Spain

    Nov 1, 2014, 00:00
  • Fda Cdx Category Medication Use During Pregnancy in the United States

    Nov 1, 2014, 00:00
  • A Comparison of Preferences for the Benefits and Risks of Statins Among Korean Physicians and Patients Using a Discrete-Choice Experiment

    Nov 1, 2014, 00:00
  • Prescribing Pattern of Antibiotics In Neonates in a Tertiary Care Hospital

    Nov 1, 2014, 00:00
  • Patient-Reported Outcomes (Pro) in Go/No-Go Decision Making in Drug Development

    Nov 1, 2014, 00:00
  • An Analysis of the Health Technology Assessment Recommendation and Guidance on Use of Eq-5d-5l in Cost-Effectiveness Modeling

    Nov 1, 2014, 00:00
  • Health Care Utilization and Costs of Breast Cancer in the Medicaid Program

    Nov 1, 2014, 00:00
  • Generic Penetration Within Top-10 Genericized Molecules – Greece Versus Major European Countries

    Nov 1, 2014, 00:00
  • The UK Cancer Drug Fund Scoring System and the Impact of the Incremental Cost Effectiveness Ratio on Funding Decisions

    Nov 1, 2014, 00:00
  • Investment Aspects of Generic Drug Policies in Countries With Severe Resource Constraints

    Nov 1, 2014, 00:00
  • Using Data Envelopment Analysis (Dea) To Rank Gp's According To Their P4p Quality and Efficiency Scores

    Nov 1, 2014, 00:00
  • Multi-Criteria Decision Analysis (MCDA)- Testing a Proposed Mcda Model for Orphan Drugs

    Nov 1, 2014, 00:00
  • The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2- A Systematic Review of Cost-Effectiveness Studies

    Nov 1, 2014, 00:00
  • Cost Effectiveness of Calcium Supplement in Reducing Preeclampsia-Related Maternal Mortality

    Nov 1, 2014, 00:00
  • A Survey of Knowledge and Attitude of Menopause Among Post-Menopausal Women in Pakistan

    Nov 1, 2014, 00:00
  • Proposed Checklist for Non-Statisticians To Assess the Quality of A Network Meta-Analysis in the Context of A Nice Submission

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy with Docetaxel

    Nov 1, 2014, 00:00
  • Mastectomy Due to Breast Cancer in Brazil- Geographic Distribution and Costs from the Public Health Care Perspective

    Nov 1, 2014, 00:00
  • Comparative Analysis of Pain Intensity in Hospice Care at Home and in Hospitals

    Nov 1, 2014, 00:00
  • Pharmacoeconomic Evaluation Study On Preoperative Treatment Of Acromegaly With Somatostatin Analogues In Shanghai

    Nov 1, 2014, 00:00
  • Economic Impact of Genetic Diagnostic Test For Breast Cancer - Health Technology Assessment in Slovak Health Care Environment

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Eltrombopag As Support Treatment In Chronic Hcv Infected Patients With Thrombocytopenia To Enable Interferon-Based Regimens

    Nov 1, 2014, 00:00
  • Effects of Drug Cost Sharing Policy on the Drug Use, Financial Risks and Moral Hazard for the Health Insurance Beneficiaries

    Nov 1, 2014, 00:00
  • Activation of Endogenous Anti-Inflammatory Mediator Cyclic Amp Confers Protection in Murine Acute Pyelonephritis Induced by Uropathogenic E Coli

    Nov 1, 2014, 00:00
  • Pre-Symptomatic Genetic Testing In Familial Amyloid Polyneuropathy- The Reproductive Options

    Nov 1, 2014, 00:00
  • The "Venous Age"- A New Tool To Sensitize Patients To Their Venous Disease

    Nov 1, 2014, 00:00
  • Patient Satisfaction Regarding their Treatment and Disease Decisions in Infra-Centimetric Breast Cancer

    Nov 1, 2014, 00:00
  • Daily Dose and Costs Associated With Maintenance Therapy of Topical Testosterone Agents Among Hypogonadal Men

    Nov 1, 2014, 00:00
  • Psychometric Validation of the Newly Developed Phenylketonuria– Quality of Life (Pku-Qol) Questionnaires Assessing the Impact of Phenylketonuria and Its Treatment On Patients' Quality of Life

    Nov 1, 2014, 00:00
  • Ophthalmology- Therapy Trends in Europe Based on Clinical Trial Registry Data

    Nov 1, 2014, 00:00
  • A Literature Review of Patient Advocacy Group (Pag) Involvement in HTA

    Nov 1, 2014, 00:00
  • What Drives Unemployment of HIV-Infected Patients in Germany?

    Nov 1, 2014, 00:00
  • Evaluating The Effect Of Immunotherapy In Advanced Non-Small- Cell Lung Cancer Patients Using Two Components Mixture Model

    Nov 1, 2014, 00:00
  • Rapid Relative Effectiveness Assessment of Pharmaceuticals- Transferability and Completeness of Information Derived From Global Value Dossiers To Complete A Eunethta Submission

    Nov 1, 2014, 00:00
  • Legal and Ethical Implications of Using Data From Social Media Websites

    Nov 1, 2014, 00:00
  • Cost Effectiveness of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in China

    Nov 1, 2014, 00:00
  • Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00
  • Mobile Phone Use in Patient Reported Outcomes– An Updated Literature Search

    Nov 1, 2014, 00:00
  • Impact Of Irritable Bowel Syndrome With Constipation On Work Productivity And Daily Activity Among Commercially Insured Patients In The United States

    Nov 1, 2014, 00:00
  • Reasons for Treatment Discontinuation of Biologics – Development and Validation of A Questionnaire

    Nov 1, 2014, 00:00
  • Examining The Role Of Insulin Pen Devices In Acute Care Settings- A Review And Analysis of Health Resource Utilization

    Nov 1, 2014, 00:00
  • The Effectiveness Of Carotid Artery Stenting Compared With Endarterectomy In Symptomatic Patients With Carotid Stenosis In Korean Multi-Center Setting

    Nov 1, 2014, 00:00
  • Traditional And Non-Traditional Risk Factors For Cardiovascular Disease In Type 2 Diabetes- Systematic Review Of Longitudinal Studies

    Nov 1, 2014, 00:00
  • The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands

    Nov 1, 2014, 00:00
  • Budget Impact Analysis of 13-Valent Pneumococcal Vaccine in Adult Population with Comorbidities or Immunocompromised from the Public Payer Perspective In Brazil

    Nov 1, 2014, 00:00
  • Self Reported Health Care Resource Use and Indirect Economic Burden of Opioid Induced Constipation (Oic)

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Infant Vaccination with 13-Valent Versus 10-Valent Pneumococcal Conjuvate Vaccine in Korea

    Nov 1, 2014, 00:00
  • Level of Testing for Potential Medication-Related Co-Morbidities for Patients Taking Antipsychotics

    Nov 1, 2014, 00:00
  • Health and economic impact of combination therapy vs. Monotherapy for treatment of benign prostatic hyperplasia in hong kong

    Nov 1, 2014, 00:00
  • Smoking Cessation Treatment Patterns and Characteristics of Patients with Copd Who are Attempting to Quit in Urban China

    Nov 1, 2014, 00:00
  • Public Preferences for Genetic Screening for Colorectal Cancer- A Discrete Choice Experiment

    Nov 1, 2014, 00:00
  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin In The Treatment And Secondary Prevention Of Acute Venous Thromboembolism In The Uk

    Nov 1, 2014, 00:00
  • Co-Administration of Turmeric Potentiates Preventive Effect of Black Seeds in Metabolic Syndrome

    Nov 1, 2014, 00:00
  • Results of A Decubitus Prevention and Wound Care Project

    Nov 1, 2014, 00:00
  • Cost Minimization Analysis Of U100 Insulin And U40 Insulin In Egyptian Diabetic Patients

    Nov 1, 2014, 00:00
  • Assessment of Health States and Erectile Dysfunction-Associated Quality of Life Among Adult Males and Females With Male Partners in Germany, the United Kingdom and the United States

    Nov 1, 2014, 00:00
  • Health Care Databases Applied to Antidepressants Use in Asia-Pacific

    Nov 1, 2014, 00:00
  • A Cost Effectiveness Analysis of Everolimus Plus Exemestane Compared to Chemotherapy Agents for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom

    Nov 1, 2014, 00:00
  • Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?

    Nov 1, 2014, 00:00
  • An Analysis of the Drivers of Pricing Premiums Granted to Innovative Products in Japan

    Nov 1, 2014, 00:00
  • The Study of Satisfaction and Reasons for Acupuncture Therapy at Sirindhorn National Medical Rehabilitation Centre

    Nov 1, 2014, 00:00
  • Impact of Patient Programs On Adherence In Inflammation and Immunology- A Global Systematic Review and Meta-Analysis of Published Evidence

    Nov 1, 2014, 00:00
  • The Burden of Health Care Costs Associated with Prostate Cancer in Ireland

    Nov 1, 2014, 00:00
  • A Gender Medicine Post-Hoc Analysis- Background and Methods of the Metagem Project

    Nov 1, 2014, 00:00
  • Evaluation of Cost Effectiveness of OM-85 in China

    Nov 1, 2014, 00:00
  • Assessing the Relationship Between Treatment Effect and Baseline Risk in Network Meta-Analsysis of Moderate to Severe Chornic Plaque Psoriasis Trials

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions

    Nov 1, 2014, 00:00
  • Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared To Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors

    Nov 1, 2014, 00:00
  • Prevalence and Associated Complication of Acute Kidney Injury Among Dengue Patients

    Nov 1, 2014, 00:00
  • Health Implications of the MTM Eligibility Criteria In The Affordable Care Act Across Racial And Ethnic Groups

    Nov 1, 2014, 00:00
  • Which is More Important for Doctors in a Low-Middle Income Country- a National Guideline or the Medical Literature? A Guideline Adherence Survey of Trastuzumab use for Breast Cancer in iran

    Nov 1, 2014, 00:00
  • Cost-Utility Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-To-Severe Active Rheumatoid Arthritis In Greece

    Nov 1, 2014, 00:00
  • Economic Impact of Levalbuterol Versus Albuterol in Low-Income Population

    Nov 1, 2014, 00:00
  • Role of Corticosteroids Use in Ards- Comparison of Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00
  • Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran

    Nov 1, 2014, 00:00
  • Non-Proliferative Diabetic Retinopathy- is It Cost-Effective to Treat Early?

    Nov 1, 2014, 00:00
  • Translation And Cultural Adaptation Difficulties Encountered During Linguistic Validation Of The Bristol Stool Scale

    Nov 1, 2014, 00:00
  • Burden of Drug Waste in Oncology- Optimization of Resource Use

    Nov 1, 2014, 00:00
  • Treatment Cost Comparison- Paliperidone Palmitate Versus Risperidone Long Acting in Brazil

    Nov 1, 2014, 00:00
  • The Performance- Volume Limit Decreased the DRG Based Acute Care Hospital Financing in hungary

    Nov 1, 2014, 00:00
  • Persistence in Health Expenditures by the Elderly in Taiwan- Predicting the Top 10% Users

    Nov 1, 2014, 00:00
  • Assessment of Validity of An Indicator Module In Identification of adverse Drug Events in Patients of Medicine Department

    Nov 1, 2014, 00:00
  • Hospitalizations And Costs In Patients With Implantable Cardioverter Defibrillators- Association Of Long Verse Standard Detection Intervals

    Nov 1, 2014, 00:00
  • Health Economic Model On the Costs and Effects of Rotavirus Vaccination in Romania

    Nov 1, 2014, 00:00
  • Use Of Computer Simulation To Generate Evidence To Aid Health Care Decision Making- An Example Using The Archimedes Model To Compare Rosuvastatin With Atorvastatin

    Nov 1, 2014, 00:00
  • Patient Adherence Among Adolescents With Arterial Hypertension

    Nov 1, 2014, 00:00
  • Determinants of Non-Persistence to Antiosteoporotic Drugs by Using Administrative Database

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Of Para-Aortic Lymphadenectomy Before Chemoradiotherapy in Locally Advanced Cervical Cancer

    Nov 1, 2014, 00:00
  • Cost Effectiveness Analysis Of Ticagrelor Versus Generic Clopidogrel In The Treatment Of Patients With Acute Coronary Syndrome In Spain

    Nov 1, 2014, 00:00
  • From Clinically Relevant Outcome Measures To Quality of Life in Epilepsy

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Aflibercept in the Treatment of Macular Oedema Secondary to Central Retinal Vein Occlusion In Sweden

    Nov 1, 2014, 00:00
  • Health-Related Quality of Life Among Tuberculosis Patients in Pakistan- A Cross Sectional Study Using WHOQOL-BREF

    Nov 1, 2014, 00:00
  • Readmittance To Hospital Within 6 Months After A Venous Thromboembolism Event- Prefer In Vte Registry

    Nov 1, 2014, 00:00
  • Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

    Nov 1, 2014, 00:00
  • Quality Of Life Assessments In Korean Patients With Rheumatoid Arthritis (Ra)- An Analysis From The Phase Iii Trial To Evaluate Equivalence Of The Etanercept Biosimilar Hd203 And Enbrel® In Combination With Methotrexate (Mtx) In Patients Wi ...

    Nov 1, 2014, 00:00
  • Efficacy and Safety of Five New Antidepression Drugs A Network Meta Analysis

    Nov 1, 2014, 00:00
  • Implications Of External Price Referencing of Pharmaceuticals in Middle East Countries

    Nov 1, 2014, 00:00
  • Loyalty To A Pharmacy Is Associated With A Better Quality Of Antidiabetes Drug Use

    Nov 1, 2014, 00:00
  • Cost-Utility Analysis Of Fidaxomicin Compared To Vancomycin In The Management Of Severe Clostridium Difficile Infection In Poland

    Nov 1, 2014, 00:00
  • Burden of Disease in Asian Countries and the use of Disability-Adjusted Life-Years and Quality-Adjusted Life-Years

    Nov 1, 2014, 00:00
  • A Budget Impact Analysis of Ustekinumab in the Management of Psoriatic Arthritis in Greece

    Nov 1, 2014, 00:00
  • Xpert Mtb/Rif Assay for Rapid Diagnosis in Patients with Suspected Tuberculosis in Hong Kong - a Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00
  • Exploring The Determinants of Endocrinologist Visits In France

    Nov 1, 2014, 00:00
  • Construct a Cpoe Decision Supporting and Monitoring System to Decrease Pims Used in Hospitalized Elderly Patients

    Nov 1, 2014, 00:00
  • Analysis of Cost-Effectiveness Assessments In France By The French National Authority For Health (Has)

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Percent Free Psa for Prostate Cancer Detection in Chinese Men with a Total Psa of 4.0-10.0 Ng/Ml

    Nov 1, 2014, 00:00
  • Epidemiology of End Stage Renal Disease Patients on Hemodialysis for Hospital Readmissions

    Nov 1, 2014, 00:00
  • Cost-Consequence Analysis of an Aprepitant Regimen Versus a Standard Antiemetic Regimen for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in Italy

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Multiple Anti-Osteoporotic Therapies for Secondary Fracture Prevention in Japan

    Nov 1, 2014, 00:00
  • Budget Impact Analysis Of Sofosbuvir For The Treatment Of Hepatitis C In The Veneto Region, Italy

    Nov 1, 2014, 00:00
  • The Socioeconomic Costs of the Undertreatment of Pain

    Nov 1, 2014, 00:00
  • Medical Costs of Cardiovascular Diseases in Taiwan

    Nov 1, 2014, 00:00
  • Study On The Direct Medical Cost of Malignant Neoplasms Inpatients With Urban Basic Health Insurance Scheme in China

    Nov 1, 2014, 00:00
  • Impact of Prior Authorization Restrictions on Resource Utilization and Costs In US Health Plans- A Review Of Literature

    Nov 1, 2014, 00:00
  • Determination of Availability of Antimicrobial Preparations for Treatment of Community-Acquired Pneumonia in Ukraine

    Nov 1, 2014, 00:00
  • Estimation of Stress Resistance of Medical Students in LVIV

    Nov 1, 2014, 00:00
  • Comparative Effectiveness in Terms of Treatment Discontinuation of Orodispersable Versus. Standard Oral Olanzapine Tablets in Non-Adherent Patients- Results from a 1-Year European Outpatient Observational Study

    Nov 1, 2014, 00:00
  • Economic Evaluation of Axitinib for Second Line Treatment in Adult Patients with Advanced Renal Cell Carcinoma – the Portuguese Case

    Nov 1, 2014, 00:00
  • The Future Health Economic Potential of Next Generation Artificial Vision Devices for Treating Blindness in Germany- an Early Cost-Utility Assessment

    Nov 1, 2014, 00:00
  • Renal Denervation With The Symplicity Catheter System For Treatment-Resistant Hypertension- A Budget Impact Analysis

    Nov 1, 2014, 00:00
  • Pain Incidence and Analgesic Consumption During Haemodialysis Sessions- Impact on Health-Related Quality Of Life

    Nov 1, 2014, 00:00
  • Drug Utilization Research in Geriatric Patients with Chronic Ischemic Heart Disease

    Nov 1, 2014, 00:00
  • Romanian Quick-HTA Development In 2013

    Nov 1, 2014, 00:00
  • Assessment of Outpatient Physiotherapy Services in Diseases of the Nervous System in Hungary

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Dapagliflozin Compared To Dpp-4 Inhibitors as Triple Therapy In Combination With Metformin and A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00
  • Retrospective Analysis of the Economic Burden of U. S. Long-Term Care Facility Residents Diagnosed with Parkinson's Disease

    Nov 1, 2014, 00:00
  • Clotting Factor (Cf) Product Use And Same-Day Risk For Thrombotic Adverse Events (Tes), As Recorded In Large Health Care Database During 2008-2013 Study Period

    Nov 1, 2014, 00:00
  • The Quality of Life of Patients Treated With Robotic Versus Traditional Surgery Results From An Italian Observational Multicenter Study

    Nov 1, 2014, 00:00
  • Current Annual Cost Calculation is the Best Predictor of Mortality at Three Years in COPD

    Nov 1, 2014, 00:00
  • The Management of Irritable Bowel Syndrome (Ibs) in England- A Real World Study in Primary Care Clinical Practice

    Nov 1, 2014, 00:00
  • The Cost Effectiveness of Group Art Therapy for Patients with Non-Psychotic Mental Health Disorders in England And Wales

    Nov 1, 2014, 00:00
  • Price Negotiation For Pharmaceuticals in Germany- High Influence Of Eu Price Weighting Method

    Nov 1, 2014, 00:00
  • Health Utility in Patients Following Cardiovascular Events

    Nov 1, 2014, 00:00
  • The Differences Between Infectious Parasitic Drug Approvals in Japan and the USA

    Nov 1, 2014, 00:00
  • Approaches Used to Model the Relationship Between Progression-Free Survival (PFS) / Time-To-Progression (TTP) And Overall Survival (OS) Within Health Economic Models of Cancer Therapies

    Nov 1, 2014, 00:00
  • Can A Cvd Polypill Save Money In The ‘Real World'?

    Nov 1, 2014, 00:00
  • A Literature Review on Cost-Effectiveness of Treatments for Wet Age-Related Maculare Degeneration

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Celecoxib In the Treatment of Patients With Chronic Pain In Japan

    Nov 1, 2014, 00:00
  • Duration of Treatment in Pulmonary Tuberculosis- are International Guidelines on the Management of Tuberculosis Missing Something?

    Nov 1, 2014, 00:00
  • A Cost-Effectiveness Analysis of Different Types of Labor for Singleton Pregnancy – Real Life Data

    Nov 1, 2014, 00:00
  • Access To Non Communicable Disease Medicines in India- A Comparative Analysis of State Level Public Procurement Data

    Nov 1, 2014, 00:00
  • Quality of Life in Pregnant Women Attending Anti-Natal Clinics in Rural and Urban Areas of Delta State

    Nov 1, 2014, 00:00
  • Is a Home Based Video Teleconcultation Setup Cost Effective For Lowering Hba1c For Patients With Type-2 Diabetes Over A Six-Month Period?

    Nov 1, 2014, 00:00
  • Transferability of Economic Evaluations To Central and Eastern Euroepan and Former Soviet Countries

    Nov 1, 2014, 00:00
  • Understanding Trends In Ophthalmologist Patient Selection And Care Based On Patterns Of Billing

    Nov 1, 2014, 00:00
  • Cost and Burden of Non-Small Cell Lung Cancer's in Portugal

    Nov 1, 2014, 00:00
  • Real World Studies Using Japanese Administrative Databases- Chronic Hepatitis C Treatment Pattern And Resource Use

    Nov 1, 2014, 00:00
  • Maintenance Daily Dose of Venlafaxine and Duloxetine in the Monotherapy of Patients with Major Depressive Disorder Resistant to Selective-Serotonin-Reuptake-Inhibitors in Routine Clinical Practice in Spain

    Nov 1, 2014, 00:00
  • The Expanding Value Footprint of Oncology Treatments

    Nov 1, 2014, 00:00
  • Understanding the Japanese General Public's Rationale for Trades in a Time-Trade-Off Assessment for Systemic Lupus Erythematosus

    Nov 1, 2014, 00:00
  • Research on Health Services Need and Utilization of the Rural Elderly Left at Home in Shaanxi Province, China

    Nov 1, 2014, 00:00
  • Generating Health State Utility Values from Fact-Ovarian Data Collected in a Phase Ii Maintenance Study in Platinum Sensitive Recurrent Ovarian Cancer (Study 19)- A Comparison of Mapping Algorithms

    Nov 1, 2014, 00:00
  • Effect of Vaccination Age on Cost-Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer in China

    Nov 1, 2014, 00:00
  • The Potential Benefits of Long-Acting Atypical Antipsycothic Therapy in Preventing Relapse in Brazil

    Nov 1, 2014, 00:00
  • Impact of Glp-1RA on Heart Rate, Blood Pressure and Hypertension Among Type 2 Diabetes- A Systematic Review and Network Meta-Analysis

    Nov 1, 2014, 00:00
  • The Risky Business of Drug Development- The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany' ...

    Nov 1, 2014, 00:00
  • Calibration And Statistical Modeling To Inform A Micro-Simulation Model For Early HTA

    Nov 1, 2014, 00:00
  • Understanding the Payer Dilemma with Biosimilar Mabs- Striking the Right Balance Between Budget Needs and Patient Outcomes

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Ipilimumab in Previously Untreated Patients With Unresectable Malignant Melanoma in Scotland

    Nov 1, 2014, 00:00
  • Systematic Review of Societal Cost of Illness Evidence in Patients With Ankylosing Spondylitis

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Of Disease Management Programs For Cardiovascular Risk And Copd In The Netherlands

    Nov 1, 2014, 00:00
  • Implications for Time Savings Using New Intraoperative Measuring Technology

    Nov 1, 2014, 00:00
  • The Opportunity of Treating Type Ii Diabetes With Dpp4i- An Economic Evaluation Verse Conventional Treatment in the Italian Setting

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage Girls

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain

    Nov 1, 2014, 00:00
  • Pain Therapy for Osteoarthritis in Germany- Analysis of Sickness Fund Claims Data

    Nov 1, 2014, 00:00
  • Reimbursement Decisions for Pharmaceuticals in Sweden- the Impact of Cost-Effectiveness and Disease Severity

    Nov 1, 2014, 00:00
  • Encepp-HTA Working Group Survey on Capacity To Conduct Research in Support Of Health Technology Assessment

    Nov 1, 2014, 00:00
  • Predictors of Adherence to Antidepressant Ýmedications in Saudi Arabia Ý

    Nov 1, 2014, 00:00
  • Does Not Reaching an Agreement on the Final Nice Scope Have Any Impact on The Final Apraisal Outcome?

    Nov 1, 2014, 00:00
  • Budget Impact Analysis Of Wider Adoption Of Biphasic Insulin Aspart (Biasp) In The Treatment Of Type 2 Diabetes Mellitus (T2dm)- A Perspective Of Patients Treated By Public Providers In Singapore

    Nov 1, 2014, 00:00
  • Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Laser Doppler Imaging in Burn Care in The Netherlands; A Randomised Controlled Trial

    Nov 1, 2014, 00:00
  • Systematic Review of the Economics of Multiple Sclerosis in Latin America

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada

    Nov 1, 2014, 00:00
  • Cost–Effectiveness of Clopidogrel-Aspirin Versus Aspirin Alone for Acute Tia and Minor Stroke

    Nov 1, 2014, 00:00
  • Health Behavior And Medication Adherence

    Nov 1, 2014, 00:00
  • Costs Related to Pneumonia, Meningitis and Sepsis in Patients 50 Years and Older from the Private Health System Perspective in Brazil

    Nov 1, 2014, 00:00
  • Adaptive Video Games can Assess and Enhance Cognitive Health

    Nov 1, 2014, 00:00
  • The Reimbursement of Expensive Drugs In Hospitals in Western European Countries

    Nov 1, 2014, 00:00
  • Constructing A Comorbidity Index According To Iso-Resource Consumption

    Nov 1, 2014, 00:00
  • Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis

    Nov 1, 2014, 00:00
  • Indirect Comparison of Exacerbation Frequency Between Aclidinium and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

    Nov 1, 2014, 00:00
  • Identification of Dry Powder Inhaler Attributes, and their Relative Importance to Asthma and Chronic Obstructive Pulmonary Disease Patients, to Inform a Discrete Choice Experiment

    Nov 1, 2014, 00:00
  • Efficacy and Safety of Paliperidone Palmitate in the Treatment of Schizophrenia- A Meta-Analysis

    Nov 1, 2014, 00:00
  • Chronic Care Management

    Nov 1, 2014, 00:00
  • Measuring the Trend of Use of Targeted Therapy and Economic Evaluation of Gefitinib for Advanced Non-Small Cell Lung Cancer (Nsclc) in Singapore

    Nov 1, 2014, 00:00
  • Creating Patient Profile in Individual Simulations- A Comparison of Approaches

    Nov 1, 2014, 00:00
  • Which Metric To Choose For Indirect Comparison Of Treatments When Multiple Comparisons Are Feasible- Lubiprostone Verse Prucalopride In Chronic Constipation

    Nov 1, 2014, 00:00
  • Direct and Indirect Costs Associated With Increasing Body Mass Index (Bmi) In the Eu5

    Nov 1, 2014, 00:00
  • Assessment Of Knowledge Regarding Diabetes- A Comparative Analysis Of Diabetes Patients And Healthy Population Of Quetta City, Pakistan

    Nov 1, 2014, 00:00
  • Evaluation of Adverse Drug Reaction (ADR) Monitoring and Reporting System in China

    Nov 1, 2014, 00:00
  • Assessing the Effectiveness AND Cost-Effectiveness of Audit and Feedback on Physician's Prescribing Indicators

    Nov 1, 2014, 00:00
  • Patients' Priorities in the Treatment of Neuroendocrine Tumors- An Analytic Hierarchy Process

    Nov 1, 2014, 00:00
  • Cost Analysis of Severe Hypoglycemia in Treated Type 2 Diabetic Patients According to Anti-Hyperglycemic Agent Therapy

    Nov 1, 2014, 00:00
  • Cost Effectiveness Analysis of A Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Italy

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy

    Nov 1, 2014, 00:00
  • Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany

    Nov 1, 2014, 00:00
  • Economic Evaluation of Agomelatine for Major Depressive Disorders Relative to other Antidepressants in the Italian Setting

    Nov 1, 2014, 00:00
  • A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan

    Nov 1, 2014, 00:00
  • Resource Use and Health Care Costs of Cervical Lesions and Cervical Cancer in Slovakia

    Nov 1, 2014, 00:00
  • Care Needs for Rheumatoid Arthritis from Patient Perspectives- A Qualitative Study from Singapore General Hospital

    Nov 1, 2014, 00:00
  • Quality of Life and the Predictors of Thai Depressive Disorders Patients

    Nov 1, 2014, 00:00
  • Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute

    Nov 1, 2014, 00:00
  • Awareness and Interest in the United States Health Insurance Marketplace

    Nov 1, 2014, 00:00
  • Health State Utilities for Pressure Ulcers – A Comparison of Condition-Specific and Generic Measures and Time-Trade-Off (Tto)

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Tocilizumab Verse Infliximab for the Patients With Rheumatoid Arthritis in Kazakhstan

    Nov 1, 2014, 00:00
  • Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

    Nov 1, 2014, 00:00
  • Potential Efficency and Cost Savings To the English Nhs By A Laparoscopic Aproach To Total Abdominal Hysterectomy

    Nov 1, 2014, 00:00
  • Health Related Quality of Life in Cancer Patients- Evaluation With A Self-Administered Ipad Application

    Nov 1, 2014, 00:00
  • Hta Epidemiology Data in Different Geographical Regions- Investigation of Requirements For Oncology Drugs

    Nov 1, 2014, 00:00
  • Comparative Efficacy And Tolerability Of Solifenacin 5mg Versus Oral Antimuscarinic Agents In Overactive Bladder (Oab)- A Systematic Literature Review (Slr) And Mixed Treatment Comparison (Mtc)

    Nov 1, 2014, 00:00
  • Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv)

    Nov 1, 2014, 00:00
  • Comparing Access to Drugs Through the CDF and by Nice – The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage

    Nov 1, 2014, 00:00
  • Development of a Longitudinal National Football League Injury and Injury Impacts (L-NFL-III) Database

    Nov 1, 2014, 00:00
  • Treatment Effect Heterogeneity in Clinical Trials- An Evaluation of 13 Large Clinical Trials Using Individual Patient Data

    Nov 1, 2014, 00:00
  • Cost of Non Small Cell Lung Cancer by Vietnamese and European Treatment Standards in Vietnam

    Nov 1, 2014, 00:00
  • Trends in Physical and Occupational Therapy Utilziation in the Us And Western Europe

    Nov 1, 2014, 00:00
  • Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs- A Dutch Demonstration Study Using the Analytic Hierarchy Process Method

    Nov 1, 2014, 00:00
  • The Econimic Cost of Rheumatoid Arthritis in Taiwan

    Nov 1, 2014, 00:00
  • Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up- Prefer In Af Registry

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of the Lidocaine 5% Medicated Plaster Verse Pregabalin and Amitriptyline for the Treatment of Post-Herpetic Neuralgia In the Netherlands

    Nov 1, 2014, 00:00
  • Differences Between Hypothetical and Experience-Based Value Sets for Eq-5d- Implications for Decision Makers

    Nov 1, 2014, 00:00
  • Home Pharmacies- An Insight In Self-Medication Practice

    Nov 1, 2014, 00:00
  • The Pension Costs of Musculoskeletal Diseases. Estimation of the Economic Burden Borne by the Italian Social Security System

    Nov 1, 2014, 00:00
  • How Successful Have Pediatric Investigation Plans Been In Stimulating Research For Pediatric Cancers?

    Nov 1, 2014, 00:00
  • Nursing Diagnosis and Some Physiological Signs and Their Changes During the Arterial Hypertension

    Nov 1, 2014, 00:00
  • Primary Treatments for Intermediate-Risk Prostate Cancer- a Cost-Effectiveness and Value-of-Information Analysis

    Nov 1, 2014, 00:00
  • A Comparison of Asian and Global Pharmaceutical Prices Using an EKS Method

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Of Mycophelonate Sodium On Patients With Renal Transplant At The Public Mexican Health Care System

    Nov 1, 2014, 00:00
  • Physicians Estimation Regarding The Impact Of Recession on Patient Adherence To Treatment In Diabetes Type 2 In Greece

    Nov 1, 2014, 00:00
  • Development of A Web-Based Tool To Elicit the Opinion of Regionally Dispersed Health Care Professionals Responsible for Medical Device Vigilance

    Nov 1, 2014, 00:00
  • Does Giving Carers a Break Improve their Wellbeing? Results from an Evaluation using the EQ-5D-5L

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis In Portugal

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients

    Nov 1, 2014, 00:00
  • Real-World Data on the Epidemiology and Treatment of HR +, HER2-Advanced Breast Cancer in Postmenopausal Patients in Different Regions of Russia for Forming Markov Models of Managment of Patients

    Nov 1, 2014, 00:00
  • Can Gastric Cancer Patients be Successfully Recruited for Clinical Phase III/IV and Health Outcome Studies Using Managed Physician Panels?

    Nov 1, 2014, 00:00
  • Relative Efficacy And Safety of Ustekinumab Compared to Anti-TNF-Alfa Therapies in Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00
  • Lipid Control After Percutaneous Coronary Intervention (PCI) in China

    Nov 1, 2014, 00:00
  • Task-Based Versus Case-Based Analysis of Time Outcomes in Multi-Country Time and Motion (TM) Studies- Methodological Considerations and Application

    Nov 1, 2014, 00:00
  • A Dutch Administrative Database in Support of Economic Evaluations- A Feasibility Study

    Nov 1, 2014, 00:00
  • Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination Program

    Nov 1, 2014, 00:00
  • Evidence-Based Medicine as a Driver of Improving Colorectal Cancer Screening in Ukraine

    Nov 1, 2014, 00:00
  • Health Economic Evaluation Comparing Iv Iron Ferric Carboxymaltose, Iron Sucrose and Blood Transfusion For Treatment of Patients with Iron Deficiency Anemia (Ida) in Singapore

    Nov 1, 2014, 00:00
  • A Systematic Literature Review to Identify Trials in First-Line Ras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) Patients

    Nov 1, 2014, 00:00
  • Systematic Review and Mixed Treatment Comparison of Lithium or an Atypical Anti-Psychotic (AAP) used to Augment a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)

    Nov 1, 2014, 00:00
  • Supporting Interoperable Eu Patient Registries- Survey of Registry Holders' Needs

    Nov 1, 2014, 00:00
  • Body Mass Index (BMI) as A Predictor of Outcome After Coronary Artery Bypass Grafting- An Asian Perspective

    Nov 1, 2014, 00:00
  • Towards Integration of Research Evidence on Patient Preferences in Coverage Decisions and Clinical Practice Guidelines- A Proposal for A Taxonomy of Preference-Related Terms

    Nov 1, 2014, 00:00
  • Burden of Varicella in Asia-Pacific Countries- A Systematic Review and Critical Analysis

    Nov 1, 2014, 00:00
  • Mapping from SF-6D to EQ-5D- Changes in Estimates Based on the Choice of Algorithm

    Nov 1, 2014, 00:00
  • Real World Management and Costs in Unresectable Metastatic Melanoma (UMM) Patients Treated at the Antwerp University Hospital (UZA)

    Nov 1, 2014, 00:00
  • High BMI and Belly fat Correlate with Prevalence of Hypertension And Diabetes- A Cross Sectional Study In Sedentary Urban Popultaion Of Delhi

    Nov 1, 2014, 00:00
  • The Cost-Effectiveness of Dapagliflozin In Combination With Insulin for the Treatment of Type 2 Diabetes Mellitus (T2dm) In Spain

    Nov 1, 2014, 00:00
  • Will Nurses Have Better Outcomes than Non-Medical Working Women when Hospitalized for Female Genital Diseases?

    Nov 1, 2014, 00:00
  • Trends in Secondary Care Costs for Treatment of Head and Neck Cancer in England

    Nov 1, 2014, 00:00
  • Cost-Effectiveness And Budget Impact Analyses Of Risk Stratification Of Patients With Moderate Risk Of Cardiovascular Events Using Lp-Pla2 Testing

    Nov 1, 2014, 00:00
  • Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cell Transplanted Patients

    Nov 1, 2014, 00:00
  • Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease- Interim Results from the Sole Study

    Nov 1, 2014, 00:00
  • Are Prices of Patent-Protected Pharamceuticals in the Top 5 Eu Countries Converging?

    Nov 1, 2014, 00:00
  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin And Rivaroxaban In The Treatment Of Acute Pulmonary Embolism In The Uk

    Nov 1, 2014, 00:00
  • Cost Minimization Analysis Of Clinical Option Scenarios For Metformin And Acarbose In Treatment Of Type 2 Diabetes- Based On Direct And Indirect Treatment Comparison Results

    Nov 1, 2014, 00:00
  • Patient Specific Landscape of Information Technology Solutions for Diabetes Self-Management

    Nov 1, 2014, 00:00
  • Long-Term Cost-Effectiveness Of Biphasic Human Insulin 30 In People With Type 2 Diabetes With Inadequate Glycaemic Control On Oral Antidiabetic Drugs In China

    Nov 1, 2014, 00:00
  • The Economic Value of Vaccination- Why Prevention Is Wealth

    Nov 1, 2014, 00:00
  • Pharmaceutical Market Access in Emerging Markets Through Innovative Patient Access Schemes

    Nov 1, 2014, 00:00
  • The Impact of Cost Containment Reforms to the Pharmaceutical Benefits Scheme (Pbs) On Prescribing Volumes And Expenditure In Australia- 1992 To 2011

    Nov 1, 2014, 00:00
  • A Systematic Review of Methods to Assess the Economic Impact of Air Pollution

    Nov 1, 2014, 00:00
  • Clinical and Demographics Characteristics of Non-Valvular Atrial Fibrillation Patients Switching From Warfarin To Novel Oral Anticoagulants

    Nov 1, 2014, 00:00
  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Models Due to Differing Patient Weights

    Nov 1, 2014, 00:00
  • The Efficiency Evaluation of the Rule From Drug Market Regulation Chamber (Cmed) Proposed To Public Medicines Acquisitions

    Nov 1, 2014, 00:00
  • Budget Impact Analysis Of Hypertensive Treatment With Indapamide And Amlodipine Single-Pill Combination In The Polish Setting

    Nov 1, 2014, 00:00
  • Quasi-Monte Carlo Simulation and Variance Reduction Techniques Substantially Reduce Computational Requirements of Patient-Level Simulation Models- an Application to a Discrete Event Simulation Model

    Nov 1, 2014, 00:00
  • New Observer-Reported Outcomes To Measure Treatment Satisfaction, Compliance, Palatability, and Gi Symptoms for Patients Needing Iron-Chelation Therapy

    Nov 1, 2014, 00:00
  • Design Methods For Study Of Prevalence, Risk Factors And Economic Burden Of Insulin Injection-Related Lipohypertrophy In China

    Nov 1, 2014, 00:00
  • A Cost-Consequence Analysis of Human Papillomavirus Vaccination in Romania

    Nov 1, 2014, 00:00
  • An Analysis of Us Medicare Beneficiaries- Burden of Direct Medical Costs in Patients With Idiopathic Pulmonary Fibrosis

    Nov 1, 2014, 00:00
  • «
  • 101 (current)
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • »